Spero Therapeutics SPRO
NASDAQ SPRO
$1.17 -0.05 (-4.10%)
At close: Oct 21, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Shares Outstanding (Entity) (2016 - 2026)

Updated

Spero Therapeutics (SPRO) recorded Shares Outstanding (Entity) of 58.15 million in Q2 2026, up 3.5% from 56.19 million a year earlier and up 0.4% from the prior quarter.

Analysis

Spero Therapeutics (SPRO) Shares Outstanding (Entity) (2016 - 2026) Analysis & Trends

For FY2025, Spero Therapeutics reported Shares Outstanding (Entity) of 56.41 million, up 3.3% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for ten straight years, with a five-year compound annual growth rate of 20.3% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Entity) came in at 54.59 million in FY2024 (+3.0%), 53 million in FY2023 (+41.0%), 37.59 million in FY2022 (+16.0%) and 32.39 million in FY2021 (+44.7%).
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2016.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased for 31 consecutive quarters, with growth averaging 3.4% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 2.5% (Q1 2024) and 60.5% (Q1 2023) over the last five years.
  • Per Business Quant, the preceding three quarters came in at 57.89 million (Q1 2026), 56.41 million (Q4 2025) and 56.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 941.36 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 2.41 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.77 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 540.60 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 1.24 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 5.70 Bn
10 Spero Therapeutics 68.40 Mn -127.38 Mn - 58.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 58.15 Mn
Mar 31, 2026 57.89 Mn
Dec 31, 2025 56.41 Mn
Sep 30, 2025 56.31 Mn
Jun 30, 2025 56.19 Mn
Mar 31, 2025 55.90 Mn
Dec 31, 2024 54.59 Mn
Sep 30, 2024 54.31 Mn
Jun 30, 2024 54.01 Mn
Mar 31, 2024 53.87 Mn
Dec 31, 2023 53.00 Mn
Sep 30, 2023 53.00 Mn
Jun 30, 2023 52.57 Mn
Mar 31, 2023 52.57 Mn
Dec 31, 2022 37.59 Mn
Sep 30, 2022 42.86 Mn
Jun 30, 2022 35.07 Mn
Mar 31, 2022 32.76 Mn
Dec 31, 2021 32.39 Mn
Sep 30, 2021 32.22 Mn
API Access

Spero Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=SPRO&period=max&api_key=YOUR_API_KEY